The Department of Health and Human Services released a policy Wednesday that would allow compounding pharmacies to make six peptides that haven't been approved by the FDA.
Copyright 2026 NPR
Sydney Lupkin
Sydney Lupkin is the pharmaceuticals correspondent for NPR, where she has reported on accelerated drug approvals whose confirmatory trials were overdue, Operation Warp Speed contract accountability, and the ripple effects of obesity drug shortages.